1Cell.AI, known until recently as OneCell Diagnostics, has announced the launch of its multimodal cancer diagnostic panel, OncoIncytes, integrating single-cell level multiomics data with ctDNA.
The panel integrates circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), RNA transcriptomics and proteomics, including analysis of 1,080 genes and 150 cellular proteins.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?